MedTrace Logo

Validation of the O3 Regional Somatic Tissue Oxygenation Monitor

NCT04584788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2022-06-27

Study results available
· View outcomes & findings →

Summary

Testing the absolute accuracy of the Masimo O3 regional oximeter in reading somatic tissue oxygenation in healthy volunteers under controlled hypoxia.

Conditions

  • Oxygen Deficiency

Interventions

DEVICE

Masimo O3 Regional Oximeter

Study sensors will be placed on somatic tissues. Readings will be taken from the tissues underneath the O3 sensors.

Sponsors & Collaborators

  • University Medical Center Groningen

    collaborator OTHER

  • Masimo Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2021-06-02
Completion
2021-06-02
FDA Device
Yes

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584788 on ClinicalTrials.gov